Publication Name	World Journal of Gastroenterology
Manuscript ID	6386
Country	Australia

Received	2013-10-15 16:11
Peer-Review Started	2013-10-16 15:10
To Make the First Decision	2014-01-15 12:22
Return for Revision	2014-01-20 12:33
Revised
Second Decision	2014-04-23 09:06
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-04-23 10:05
Articles in Press	2014-05-23 10:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-17 16:41
Publish the Manuscript Online	2014-08-07 10:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Preventing infective complications in inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Justine Mill and Ian C Lawrance
Funding Agency and Grant Number
Corresponding Author	Ian C Lawrance, Professor, Department of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Alma Street, Fremantle, WA 6059, Australia. ian.lawrance@uwa.edu.au
Key Words	Infection; Complications; Inflammatory bowel diseases; Immunosuppression; Anti-tumor necrosis factor agents
Core Tip	In inflammatory bowel diseases (IBD) there is increasing use of immunosuppressives and the biological agents, which are being used earlier in the course of disease, and for longer durations. This, however, has the potential to increase the risk of opportunistic and serious infections in these patients, most of which are preventable. A balance thus needs to be struck between medication use to control the disease with minimization of the risk of an opportunistic infection. This outcome is achieved by the physician’s tailored use of justified therapies, and the patients’ education and actions to minimize infection risk. The purpose of this review is to explore the evidence and guidelines available to all physicians managing patients with IBD.
Publish Date	2014-08-07 10:34
Citation	Mill J, Lawrance IC. Preventing infective complications in inflammatory bowel disease. World J Gastroenterol 2014; 20(29): 9691-9698
URL	http://www.wjgnet.com/1007-9327/full/v20/i29/9691.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i29.9691

Full Article (PDF)	WJG-20-9691.pdf
Full Article (Word)	WJG-20-9691.doc
Manuscript File	6386-Review.docx
Answering Reviewers	6386-Answering reviewers.pdf
Copyright License Agreement	6386-Copyright assignment.pdf
Peer-review Report	6386-Peer reviews.pdf
Scientific Editor Work List	6386-Scientific editor work list.doc